Position in BMY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$242,580
New position
Shares Held
4,210
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,016
of 2,506 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Johnson Financial Group, LLC holds $7,394,397 across 9 Drug Manufacturers - General names. BMY ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
6,650 | $1,673,406 | |
| 2 | LLY |
ELI LILLY & Co
|
1,147 | $1,375,746 | |
| 3 | JNJ |
Johnson & Johnson
|
4,823 | $1,224,897 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,613 | $1,106,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,967 | $880,210 | |
| 6 | AMGN |
Amgen Inc
|
1,188 | $430,198 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
4,210 | $242,580 | |
| 8 | SNY |
Sanofi
|
5,501 | $234,672 |
All Filings in BMY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,580 | 4,210 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||